Your browser doesn't support javascript.
loading
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Kaczmarek, Krystian; Plage, Henning; Furlano, Kira; Hofbauer, Sebastian; Weinberger, Sarah; Ralla, Bernhard; Franz, Antonia; Fendler, Annika; de Martino, Michela; Roßner, Florian; Schallenberg, Simon; Elezkurtaj, Sefer; Kluth, Martina; Lennartz, Maximilian; Blessin, Niclas C; Marx, Andreas H; Samtleben, Henrik; Fisch, Margit; Rink, Michael; Slojewski, Marcin; Ecke, Thorsten; Hallmann, Steffen; Koch, Stefan; Adamini, Nico; Minner, Sarah; Simon, Ronald; Sauter, Guido; Weischenfeldt, Joachim; Klatte, Tobias; Schlomm, Thorsten; Horst, David; Zecha, Henrik.
Afiliación
  • Kaczmarek K; Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland.
  • Plage H; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Furlano K; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Hofbauer S; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Weinberger S; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Ralla B; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Franz A; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Fendler A; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • de Martino M; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Roßner F; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Schallenberg S; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Elezkurtaj S; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Lennartz M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Blessin NC; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Marx AH; Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany.
  • Samtleben H; Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany.
  • Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rink M; Department of Urology, Marienhospital Hamburg, Hamburg, Germany.
  • Slojewski M; Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland.
  • Ecke T; Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany.
  • Hallmann S; Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany.
  • Koch S; Department of Pathology, Helios Hospital Bad Saarow, Bad Saarow, Germany.
  • Adamini N; Department of Urology, Albertinen Hospital, Hamburg, Germany.
  • Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. R.Simon@uke.de.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Weischenfeldt J; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Klatte T; Biotech Research & Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Schlomm T; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.
  • Horst D; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Zecha H; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Int Urol Nephrol ; 56(2): 499-508, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37777995

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Límite: Humans Idioma: En Revista: Int Urol Nephrol Año: 2024 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Límite: Humans Idioma: En Revista: Int Urol Nephrol Año: 2024 Tipo del documento: Article País de afiliación: Polonia